5240 articles
Isaac Turner, Ph.D., Co-Founder and Chief Technology Officer at Curative, a next-generation healthcare company that pivoted to COVID testing in March 20...
Returning guest, Brian Culley, CEO of Lineage Cell Therapeutics, a clinical-stage biotechnology company, discusses the latest clinical advancements with...
Alexander Roediger, Global Lead Oncology Policy at Merck & Co, Inc. Learn more on Health Professional Radio.
Libby Copeland-Halperin, a diplomate of the American Board of Surgery and a candidate member of the American Society of Plastic Surgeons discusses a new...
Jorge DiMartino, MD, PhD, Chief Medical Officer and Executive VP of Clinical Development at Kronos Bio, discusses the company’s three investigational ...
Harmony Garges, Chief Medical Officer at ViiV Healthcare, a company dedicated to HIV medicines, research, and the people affected by HIV and AIDS discus...
Andrew Salzman, MD, Chief Science Officer at Innovation1 Biotech, a company that is modifying Schedule 1 molecules and creating drug innovation in the f...
Stan Abel, CEO of ProJenX, the company leading the way in the development of targeted therapies to address significant unmet medical needs in degenera...
Mark Varney, Ph.D., Chief Scientific Officer of PsychoGenics, an AI-enabled phenotypic drug discovery and preclinical contract research organization (CR...
Larry Edwards, Professor of Medicine, Division of Rheumatology and Clinical Immunology, Program Director and Vice Chairman of the Department of Medicine...